Poolbeg Pharma (LON:POLB) Reaches New 52-Week Low – Here’s What Happened

Poolbeg Pharma PLC (LON:POLB)’s stock price reached a new 52-week low on Thursday . The stock traded as low as GBX 4.11 ($0.05) and last traded at GBX 4.27 ($0.05), with a volume of 28485160 shares traded. The stock had previously closed at GBX 7.10 ($0.09).

Wall Street Analysts Forecast Growth

Separately, Shore Capital reissued a “house stock” rating on shares of Poolbeg Pharma in a research note on Thursday.

Poolbeg Pharma Trading Down 39.9 %

The company has a market capitalization of £21.35 million, a PE ratio of -427.00 and a beta of 2.11. The firm’s 50-day simple moving average is GBX 7.66 and its 200-day simple moving average is GBX 10.08.

About Poolbeg Pharma

Poolbeg Pharma plc is focussed on the development and commercialisation of innovative medicines targeting serious diseases with a high unmet medical need. Its model focusses upon developing its exciting clinical assets and commercialising approved and marketed drugs to support the growth of the Company and the development of its robust pipeline of innovative products, thereby driving significant value creation.

Poolbeg is led by an experienced leadership team with a history of delivering significant shareholder value.